Publications by authors named "Charlotta Hedner"

Claim this Profile
T
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
Konstantinos S Papadakos, Gilar Gorji-Bahri, Chrysostomi Gialeli, Charlotta Hedner, Catharina Hagerling

Cancer Immunol Immunother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers.
Artur Mezheyeuski, Max Backman, Johanna Mattsson, Alfonso Martín-Bernabé, Chatarina Larsson, Charlotta Hedner

EBioMedicine· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Infiltration of CD68+/CD163- Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma.
Maria C Svensson, Maja Svensson, Björn Nodin, David Borg, Charlotta Hedner

J Innate Immun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival.
Maria Christina Svensson, Albin Lindén, Jakob Nygaard, David Borg, Charlotta Hedner

Oncoimmunology· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types.
Patrick Micke, Carina Strell, Johanna Mattsson, Alfonso Martín-Bernabé, Hans Brunnström, Charlotta Hedner

EBioMedicine· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers.
Cathy E Richards, Katherine M Sheehan, Elaine W Kay, Charlotta Hedner, David Borg

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Associated CD68, CD163, and MARCO Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma.
Martin Jeremiasen, David Borg, Charlotta Hedner, Maria Svensson, Björn Nodin

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival.
Maria C Svensson, David Borg, Cheng Zhang, Charlotta Hedner, Björn Nodin

Front Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.
David Borg, Anna H Larsson, Charlotta Hedner, Björn Nodin, Anders Johnsson

J Transl Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Charlotta Hedner, David Borg, Björn Nodin, Emelie Karnevi, Karin Jirström

J Clin Pathol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma.
Maria C Svensson, Carl Fredrik Warfvinge, Richard Fristedt, Charlotta Hedner, David Borg

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma.
Richard Fristedt, David Borg, Charlotta Hedner, Jonna Berntsson, Björn Nodin

J Gastrointest Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.
David Borg, Charlotta Hedner, Björn Nodin, Anna Larsson, Anders Johnsson

BMC Clin Pathol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
Charlotta Hedner, David Borg, Björn Nodin, Emelie Karnevi, Karin Jirström

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma.
David Borg, Charlotta Hedner, Alexander Gaber, Björn Nodin, Richard Fristedt

Biomark Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.
Charlotta Hedner, Lena Tran, David Borg, Björn Nodin, Karin Jirström

Histopathology· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.
Charlotta Hedner, Alexander Gaber, Dejan Korkocic, Björn Nodin, Mathias Uhlén

Virchows Arch· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
Liv Jonsson, Charlotta Hedner, Alexander Gaber, Dejan Korkocic, Björn Nodin

Biomark Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
Richard Fristedt, Alexander Gaber, Charlotta Hedner, Björn Nodin, Mathias Uhlén

J Transl Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between presence of relevant information in referrals to radiology and prevalence rates in patients with suspected pulmonary embolism.
Charlotta Hedner, Pia C Sundgren, Aine Marie Kelly

Acad Radiol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer.
Björn Nodin, Charlotta Hedner, Mathias Uhlén, Karin Jirström

J Ovarian Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis